Schlenstedt Christian, Mancini Martina, Horak Fay, Peterson Daniel
Department of Neurology, School of Medicine, Oregon Health & Science University, Portland, OR; Department of Neurology, University Hospital Schleswig-Holstein, Christian-Albrechts-University, Kiel, Germany.
Department of Neurology, School of Medicine, Oregon Health & Science University, Portland, OR.
Arch Phys Med Rehabil. 2017 Jul;98(7):1316-1324.e1. doi: 10.1016/j.apmr.2017.01.023. Epub 2017 Feb 28.
To characterize anticipatory postural adjustments (APAs) across a variety of step initiation tasks in people with Parkinson disease (PD) and healthy subjects.
Cross-sectional study. Step initiation was analyzed during self-initiated gait, perceptual cued gait, and compensatory forward stepping after platform perturbation. People with PD were assessed on and off levodopa.
University research laboratory.
People (N=31) with PD (n=19) and healthy aged-matched subjects (n=12).
Not applicable.
Mediolateral (ML) size of APAs (calculated from center of pressure recordings), step kinematics, and body alignment.
With respect to self-initiated gait, the ML size of APAs was significantly larger during the cued condition and significantly smaller during the compensatory condition (P<.001). Healthy subjects and patients with PD did not differ in body alignment during the stance phase prior to stepping. No significant group effect was found for ML size of APAs between healthy subjects and patients with PD. However, the reduction in APA size from cued to compensatory stepping was significantly less pronounced in PD off medication compared with healthy subjects, as indicated by a significant group by condition interaction effect (P<.01). No significant differences were found comparing patients with PD on and off medications.
Specific stepping conditions had a significant effect on the preparation and execution of step initiation. Therefore, APA size should be interpreted with respect to the specific stepping condition. Across-task changes in people with PD were less pronounced compared with healthy subjects. Antiparkinsonian medication did not significantly improve step initiation in this mildly affected PD cohort.
描述帕金森病(PD)患者和健康受试者在各种起始步任务中的预期姿势调整(APA)。
横断面研究。在自发步态、感知提示步态以及平台扰动后的代偿性向前迈步过程中分析起始步。对服用和未服用左旋多巴的PD患者进行评估。
大学研究实验室。
31人,其中PD患者19人,年龄匹配的健康受试者12人。
不适用。
APA的内外侧(ML)大小(根据压力中心记录计算)、步运动学和身体对线情况。
关于自发步态,提示条件下APA的ML大小显著更大,代偿条件下显著更小(P<0.001)。在迈步前的站立期,健康受试者和PD患者的身体对线情况无差异。健康受试者和PD患者之间APA的ML大小未发现显著的组间效应。然而,与健康受试者相比,未服用药物的PD患者从提示迈步到代偿迈步时APA大小的减小明显不那么显著,这由显著的组×条件交互效应表明(P<0.01)。比较服用和未服用药物的PD患者未发现显著差异。
特定的迈步条件对起始步的准备和执行有显著影响。因此,应根据特定的迈步条件来解释APA大小。与健康受试者相比,PD患者跨任务的变化不那么明显。在这个轻度受影响的PD队列中,抗帕金森药物并未显著改善起始步。